These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32210242)

  • 1. A Staphylococcus pro-apoptotic peptide induces acute exacerbation of pulmonary fibrosis.
    D'Alessandro-Gabazza CN; Kobayashi T; Yasuma T; Toda M; Kim H; Fujimoto H; Hataji O; Takeshita A; Nishihama K; Okano T; Okano Y; Nishii Y; Tomaru A; Fujiwara K; D'Alessandro VF; Abdel-Hamid AM; Ren Y; Pereira GV; Wright CL; Hernandez A; Fields CJ; Yau PM; Wang S; Mizoguchi A; Fukumura M; Ohtsuka J; Nosaka T; Kataoka K; Kondoh Y; Wu J; Kawagishi H; Yano Y; Mackie RI; Cann I; Gabazza EC
    Nat Commun; 2020 Mar; 11(1):1539. PubMed ID: 32210242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulation by mesenchymal stem cells in treating human autoimmune disease-associated lung fibrosis.
    Liu M; Zeng X; Wang J; Fu Z; Wang J; Liu M; Ren D; Yu B; Zheng L; Hu X; Shi W; Xu J
    Stem Cell Res Ther; 2016 Apr; 7(1):63. PubMed ID: 27107963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of lung microbiota-derived proapoptotic peptides ameliorates acute exacerbation of pulmonary fibrosis.
    D'Alessandro-Gabazza CN; Yasuma T; Kobayashi T; Toda M; Abdel-Hamid AM; Fujimoto H; Hataji O; Nakahara H; Takeshita A; Nishihama K; Okano T; Saiki H; Okano Y; Tomaru A; Fridman D'Alessandro V; Shiraishi M; Mizoguchi A; Ono R; Ohtsuka J; Fukumura M; Nosaka T; Mi X; Shukla D; Kataoka K; Kondoh Y; Hirose M; Arai T; Inoue Y; Yano Y; Mackie RI; Cann I; Gabazza EC
    Nat Commun; 2022 Mar; 13(1):1558. PubMed ID: 35322016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory T Cells Limit Pneumococcus-Induced Exacerbation of Lung Fibrosis in Mice.
    Moyé S; Bormann T; Maus R; Sparwasser T; Sandrock I; Prinz I; Warnecke G; Welte T; Gauldie J; Kolb M; Maus UA
    J Immunol; 2020 May; 204(9):2429-2438. PubMed ID: 32213566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR10+ epithelial cells from idiopathic pulmonary fibrosis lungs drive remodeling.
    Habiel DM; Espindola MS; Jones IC; Coelho AL; Stripp B; Hogaboam CM
    JCI Insight; 2018 Aug; 3(16):. PubMed ID: 30135312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Microbiome-Derived Peptide Induces Apoptosis of Cells from Different Tissues.
    Saiki H; Okano Y; Yasuma T; Toda M; Takeshita A; Abdel-Hamid AM; Fridman D'Alessandro V; Tsuruga T; D'Alessandro-Gabazza CN; Katayama K; Sugimoto M; Fujimoto H; Yamanaka K; Kobayashi T; Cann I; Gabazza EC
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streptococcus pneumoniae triggers progression of pulmonary fibrosis through pneumolysin.
    Knippenberg S; Ueberberg B; Maus R; Bohling J; Ding N; Tort Tarres M; Hoymann HG; Jonigk D; Izykowski N; Paton JC; Ogunniyi AD; Lindig S; Bauer M; Welte T; Seeger W; Guenther A; Sisson TH; Gauldie J; Kolb M; Maus UA
    Thorax; 2015 Jul; 70(7):636-46. PubMed ID: 25964315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of the mouse model of acute exacerbation of idiopathic pulmonary fibrosis.
    Wei YR; Qiu H; Wu Q; Du YK; Yin ZF; Chen SS; Jin YP; Zhao MM; Wang C; Weng D; Li HP
    Exp Lung Res; 2016; 42(2):75-86. PubMed ID: 27070485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Danger-associated molecular patterns and danger signals in idiopathic pulmonary fibrosis.
    Ellson CD; Dunmore R; Hogaboam CM; Sleeman MA; Murray LA
    Am J Respir Cell Mol Biol; 2014 Aug; 51(2):163-8. PubMed ID: 24749648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis.
    O'Dwyer DN; Ashley SL; Gurczynski SJ; Xia M; Wilke C; Falkowski NR; Norman KC; Arnold KB; Huffnagle GB; Salisbury ML; Han MK; Flaherty KR; White ES; Martinez FJ; Erb-Downward JR; Murray S; Moore BB; Dickson RP
    Am J Respir Crit Care Med; 2019 May; 199(9):1127-1138. PubMed ID: 30789747
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased Galectin-9 Concentration and Number of CD4+Foxp3high+Cells in Bronchoalveolar Lavage Fluid of Patients with Cryptogenic Organizing Pneumonia.
    Katoh S; Ikeda M; Shimizu H; Abe M; Ohue Y; Mouri K; Kobashi Y; Oka M
    Lung; 2015 Oct; 193(5):683-9. PubMed ID: 26249221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis.
    Gui X; Qiu X; Tian Y; Xie M; Li H; Gao Y; Zhuang Y; Cao M; Ding H; Ding J; Zhang Y; Cai H
    Int Immunopharmacol; 2019 May; 70():208-215. PubMed ID: 30851700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
    Zhang L; Li Y; Liang C; Yang W
    Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-26a suppresses EMT by disrupting the Lin28B/let-7d axis: potential cross-talks among miRNAs in IPF.
    Liang H; Liu S; Chen Y; Bai X; Liu L; Dong Y; Hu M; Su X; Chen Y; Huangfu L; Li X; Gu Y; Shan H
    J Mol Med (Berl); 2016 Jun; 94(6):655-65. PubMed ID: 26787543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and preclinical efficacy of novel transforming growth factor-β1 short interfering RNAs for pulmonary fibrosis.
    D'Alessandro-Gabazza CN; Kobayashi T; Boveda-Ruiz D; Takagi T; Toda M; Gil-Bernabe P; Miyake Y; Yasukawa A; Matsuda Y; Suzuki N; Saito H; Yano Y; Fukuda A; Hasegawa T; Toyobuku H; Rennard SI; Wagner PD; Morser J; Takei Y; Taguchi O; Gabazza EC
    Am J Respir Cell Mol Biol; 2012 Mar; 46(3):397-406. PubMed ID: 22033267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prominin-1/CD133+ lung epithelial progenitors protect from bleomycin-induced pulmonary fibrosis.
    Germano D; Blyszczuk P; Valaperti A; Kania G; Dirnhofer S; Landmesser U; Lüscher TF; Hunziker L; Zulewski H; Eriksson U
    Am J Respir Crit Care Med; 2009 May; 179(10):939-49. PubMed ID: 19234103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of permeability alteration and epithelial-mesenchymal transition induced by transforming growth factor-β
    Togami K; Yamaguchi K; Chono S; Tada H
    J Pharmacol Toxicol Methods; 2017 Jul; 86():19-27. PubMed ID: 28259823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of TIM-3 in Macrophages Aggravates Pathogenesis of Pulmonary Fibrosis in Mice.
    Wang Y; Kuai Q; Gao F; Wang Y; He M; Zhou H; Han G; Jiang X; Ren S; Yu Q
    Am J Respir Cell Mol Biol; 2019 Dec; 61(6):727-736. PubMed ID: 31162951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study.
    Han MK; Zhou Y; Murray S; Tayob N; Noth I; Lama VN; Moore BB; White ES; Flaherty KR; Huffnagle GB; Martinez FJ;
    Lancet Respir Med; 2014 Jul; 2(7):548-56. PubMed ID: 24767767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta 1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells.
    Hagimoto N; Kuwano K; Inoshima I; Yoshimi M; Nakamura N; Fujita M; Maeyama T; Hara N
    J Immunol; 2002 Jun; 168(12):6470-8. PubMed ID: 12055267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.